Justin Kang
About Justin Kang
Justin Kang is the Associate Director of Zeposia Pricing & Contracting Strategy at Bristol Myers Squibb, with extensive experience in strategic payer marketing and clinical program management.
Current Position at Bristol Myers Squibb
Justin Kang currently holds the position of Associate Director - Zeposia Pricing & Contracting Strategy at Bristol Myers Squibb. In his role, he is responsible for developing and implementing pricing and contracting strategies for the pharmaceutical product Zeposia. His work involves liaising with various stakeholders to ensure that Zeposia is competitively priced and accessible to patients who need it.
Previous Roles at Bristol Myers Squibb
Before becoming Associate Director, Justin served as the Senior Manager of Strategic Payer Marketing for Zeposia at Bristol Myers Squibb from 2019 to 2021. During this time, he focused on strategic marketing initiatives aimed at payer organizations to ensure market access and reimbursement for Zeposia. His efforts contributed to the effective positioning of the drug within the marketplace.
Experience at Celgene
In 2019, Justin Kang worked at Celgene as Senior Manager of Access and Value Marketing for Zeposia for five months. His tenure at Celgene was cut short due to the company's acquisition by Bristol Myers Squibb, at which point he transitioned to his role at Bristol Myers Squibb. At Celgene, he contributed to access and value marketing strategies designed to maximize the drug's reach and effectiveness.
Clinical Program Management at Prime Therapeutics
From 2017 to 2019, Justin served as the Director of Clinical Program Management at Prime Therapeutics. In this capacity, he managed clinical programs aimed at improving patient outcomes and optimizing clinical operations. This role allowed him to cultivate a deep understanding of clinical program management processes and patient care strategies.
Educational Background in Pharmacy
Justin Kang holds a Doctor of Pharmacy (Pharm.D.) degree from Rutgers University-New Brunswick, where he studied from 2005 to 2011. His formal education in pharmacy laid the foundation for his extensive career in the pharmaceutical industry. The comprehensive curriculum at Rutgers University equipped him with the knowledge and skills needed to excel in various roles, from clinical to strategic positions.